Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 27, 2026.

Ethanol and Cognition: Indirect Effects, Neurotoxicity and Neuroprotection: A Review

John Brust

International Journal of Environmental Research and Public Health · 2010 · Review · CC BY

doi:10.3390/ijerph7041540

Abstract

Ethanol affects cognition in a number of ways. Indirect effects include intoxication, withdrawal, brain trauma, central nervous system infection, hypoglycemia, hepatic failure, and Marchiafava-Bignami disease. Nutritional deficiency can cause pellagra and Wernicke-Korsakoff disorder. Additionally, ethanol is a direct neurotoxin and in sufficient dosage can cause lasting dementia. However, ethanol also has neuroprotectant properties and in low-to-moderate dosage reduces the risk of dementia, including Alzheimer type. In fetuses ethanol is teratogenic, and whether there exists a safe dose during pregnancy is uncertain and controversial.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 27, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

The term “alcoholic” is applied to those who are psychically dependent (addicted) to ethanol—that is, craving for ethanol is a daily preoccupation. It is also applied to those who are physically dependent on ethanol—that is, cessation of drinking causes physical withdrawal symptoms and signs. The term is sometimes extended to include “problem drinkers”, who may be neither psychically nor physically dependent on ethanol but who get into trouble when they drink. In the United States it is estimated that 7% of adults and 19% of adolescents are alcoholics or problem drinkers and that ethanol accounts for more than 100,000 deaths per year or 5% of all mortality. As with other reinforcing drugs, alcohol addiction—i.e., compulsive use, craving—depends on mesolimbic dopaminergic pathways of the so-called “reward system”.

Indirect Effects

Ethanol can alter mentation in a variety of ways. Affecting many neurotransmitter systems, ethanol inhibits excitatory glutamate receptors and facilitates inhibitory γ-aminobutyric acid (GABA) receptors. Early symptoms of acute intoxication—euphoria and disinhibition—progress to stupor and respiratory depression. Perhaps reflecting glutamate receptor up-regulation and GABA-receptor down-regulation, abrupt abstinence after prolonged or binge drinking can result in tremor, hallucinations (visual, auditory, or tactile), seizures, or delirium tremens, with severely constricted attentiveness, fluctuating levels of alertness, agitation, and autonomic instability. It is possible, moreover, that repeated binges and withdrawals cause not only early abstinence symptoms but also glutamate-induced excitotoxicity and permanent neuronal damage, in turn contributing to more lasting neurological disorders, including dementia.

Other causes of acutely altered mentation in heavy drinkers include cerebral trauma, meningitis, hypoglycemia, hepatic encephalopathy, alcoholic ketoacidosis and concomitant use of other agents such as cocaine or heroin. Marchiafava-Bignami disease, a rare disorder nearly always diagnosed in alcoholics, causes mania, depression, paranoia, and dementia, plus seizures, paresis, and ataxia, and often progresses to coma and death within a few months; symptoms are not readily explained by the prominent corpus callosum demyelination that is the pathological hallmark of this poorly understood disease.

Nutritional Deficiency Disorders

Often deficient in thiamine, nicotinic acid, other B vitamins, and folate, alcoholics frequently develop neurological disorders associated with malnutrition, including cerebellar degeneration, amblyopia, polyneuropathy, and disorders affecting cognition. In pellagra nicotinic acid deficiency results in skin, gastrointestinal, and mental abnormalities which can progress to memory impairment, delusions, hallucinations, dementia, or delirium; hypertonus and startle myoclonus may be present. Symptoms usually improve following treatment with nicotinic acid or nicotinamide.

A more frequently encountered nutritional disorder in alcoholics is Wernicke–Korsakoff disease. Wernicke and Korsakoff syndromes share the same pathology—characteristic histological abnormalities within the medial and anterior thalamus, hypothalamus (including the mammillary bodies), and periaqueductal grey matter of the midbrain, but they have different clinical features. Wernicke syndrome consists of abnormal mentation, abnormal eye movements, and gait ataxia. Mental abnormalities include varying combinations of inattentiveness, abulia (apathy), and impaired memory progressing in the absence of treatment to coma. Eye movement abnormalities begin with limitations of abduction or horizontal gaze and progress to ophthalmoplegia. Gait ataxia progresses to inability to stand. Patients are thiamine-deficient, and symptoms rapidly improve when thiamine is replaced in a timely fashion. Improvement is often less than complete, however. A patient may be left with nystagmus and a broad-based gait, and the multi-domain cognitive impairment may evolve into a more selective amnestic disorder—Korsakoff syndrome. How often Korsakoff syndrome occurs in the absence of antecedent Wernicke syndrome is uncertain. Autopsies have revealed Wernicke-Korsakoff pathology in patients unsuspected of having Wernicke syndrome prior to death.

Clinical evidence suggests that Wernicke syndrome is more likely to occur in nutritionally deficient alcoholics than in comparably deficient non-alcoholics. In developing countries, thiamine deficiency in a non-alcoholic is more likely to produce beri-beri with cardiac failure and polyneuropathy than Wernicke syndrome. (On the other hand, several of Korsakoff’s original patients had not been heavy drinkers.) A biologically plausible mechanism by which thiamine deficiency and ethanol could have additive or even synergistic effects on cognition involves glutamate. Thiamine deficiency causes excessive glutamate release and thus like ethanol has the potential to cause excitotoxic neuronal damage. When thiamine-induced glutamate release is combined with ethanol-induced glutamate receptor up-regulation, the potential for excitotoxicity would be compounded. In anecdotal reports patients with Wernicke-Korsakoff syndrome have experienced symptomatic improvement following treatment with the glutamate NMDA receptor antagonist memantine. (They have also reportedly improved after treatment with cholinergic agents such as donepezil and rivastigmine.)

A combined effect of nutritional deficiency and direct ethanol toxicity appears operative in other neurological disorders encountered in alcoholics. Cerebellar degeneration can occur with severe nutritional deprivation in both drinkers and non-drinkers. Animal studies, however, demonstrate neurotoxic effects of ethanol on cerebellar granule and Purkinje cells. Optic atrophy in heavy drinkers (formerly called “tobacco-alcohol amblyopia”) improves with nutritional supplementation, but it is likely that ethanol toxicity (as well as, perhaps, neurotoxic compounds in tobacco smoke) are contributory. Polyneuropathy in alcoholics similarly appears to have two causes. In a study comparing polyneuropathy in thiamine-deficient drinkers, thiamine-deficient non-drinkers, and alcoholics without thiamine deficiency, polyneuropathy attributable to thiamine deficiency alone was motor-dominant and rapidly progressive, impaired both superficial and deep sensation, and caused predominantly large-fiber axonal loss. Polyneuropathy in alcoholics without thiamine deficiency was sensory-dominant, slowly progressive, impaired superficial sensation, and caused predominantly small-fiber axonal loss. Thiamine-deficient alcoholics tended to have a mixture of the two types.

Alcoholic Dementia

In recent decades it has become increasingly evident that ethanol can cause lasting cognitive impairment—“alcoholic dementia” or “ethanol-related dementia”—in the absence of nutritional deficiency, cerebral trauma, hepatic failure, or other indirect forms of brain injury. Many alcoholics demonstrate gradually progressive multi-domain cognitive impairment rather than a more restrictive amnestic disorder, a prior history of Wernicke syndrome is often lacking, and there may be little evidence of past or present nutritional deficiency. Computerized tomographic (CT) scanning shows ventricular and sulcal enlargement unexplained by the neuropathology of Wernicke-Korsakoff syndrome, and the observed brain shrinkage reportedly improves with abstinence.

Ethanol-related dementia has been estimated to represent roughly 10% of all cases of dementia, and “heavy alcohol use” probably contributes to many more. Proposed criteria for ethanol-related dementia include dementia for at least 60 days after last exposure to ethanol, minimum 35 standard drinks per week for males and 28 for females for more than 5 years, and significant ethanol use within 3 years of the onset of impaired cognition.

Animal studies using pair-fed controls confirm that ethanol is neurotoxic, and in exposed animals neuropathological changes correlate with impaired memory and learning. Reported abnormalities include loss of hippocampal CA1 and CA3 pyramidal neurons, mossy fiber-CA3 synapses, and dentate granule cells; loss of cholinergic neurons in the basal forebrain; pathological changes in neurons of cerebral cortex, hypothalamus, and brainstem; and impaired pruning of redundant cortical synapses during early development. Damage is dose-related and especially likely with binge drinking that produces high blood ethanol concentrations (BEC).

Nutritional deficiency can be difficult to exclude in cognitively impaired heavy drinkers, but there is convincing evidence of brain damage in “uncomplicated alcoholics”. Transcranial magnetic stimulation in chronic alcoholics demonstrates significant prolongation of central motor conduction time. Quantitative neuroimaging suggests association of cognitive impairment with damaged pontocerebellar and cerebellothalamocortical systems. Cerebral white matter volume loss is prominent, and MRI, including diffusion-weighted imaging, reveals involvement of structural elements rather than water loss. Such changes in cerebral white matter are at least partly reversible, although it is less clear whether cognitive improvement accompanies improvement on imaging. Magnetic resonance spectroscopy reveals damage to white matter phospholipids in the absence of white matter volume loss. White matter abnormalities, including excessive intra- and extracellular fluid, have also been identified with diffusion tensor imaging.

In human studies neuronal loss is described in many brain areas, most consistently the superior frontal association cortex, hypothalamus, and cerebellum, and less consistently the hippocampus, amygdala, and locus coeruleus. Basal ganglia and serotonergic raphe nuclei appear to be unaffected. Using the neuronal/axonal marker N-acetyl aspartate (NAA), magnetic resonance spectroscopy confirmed the special vulnerability of pre-frontal cortex in alcoholics, and abnormalities in planning, organization, problem solving, and abstracting, as well as lack of insight, disinhibition, and perseveration are consistent with these regional vulnerabilities. Early changes in dendrites, receptors, and neurotransmitters probably produce cognitive impairment in advance of gross morphological change. Women appear to be more susceptible than men to the adverse effects of ethanol, exhibiting earlier changes yet greater recovery with abstinence. The likelihood of cognitive impairment may be greater in subjects with repeated prior episodes of symptomatic withdrawal.

Ethanol neurotoxicity may have several mechanisms, including glutamate excitotoxicity and oxidative stress, exacerbated in some cases by thiamine deficiency. In an open label study of 19 patients with probable ethanol-related dementia, cognitive improvement followed treatment with the glutamate NMDA receptor antagonist memantine. (As noted, Wernicke-Korsakoff syndrome also reportedly benefits from memantine therapy.) In rat hippocampal slice cultures subjected to 10 days of in vitro ethanol followed by 24 hours of withdrawal, memantine effectively blocked ethanol withdrawal-induced neurotoxicity. (Interestingly, memantine also appears to reduce craving in subjects dependent on ethanol.)

Homocysteine is also implicated in ethanol neurotoxicity; hyperhomocysteinemia follows folate deficiency, and homocysteine acts as an agonist at glutamate NMDA receptors, increasing NMDA receptor transmission and the potential for excitotoxicity. Ethanol also reduces the availability of brain-neurotrophic factor and nerve growth factor, possibly resulting in impaired intracellular signaling pathways. Ethanol-induced DNA strand breaks might cause neuronal death. In animals protein adduct formation with the ethanol metabolite acetaldehyde was found in frontal lobe cortex and white matter.

Just as thiamine deficiency may interact synergistically with alcohol neurotoxicity to produce cognitive impairment, other neurological disorders encountered in alcoholics, including hepatic encephalopathy and prior cerebral trauma or hypoglycemia, could also be contributory. Also operative might be age of onset of drinking and genetic vulnerability.

Attempts to define a safe dose threshold for ethanol have been inconsistent. A review of 19 published studies addressing this issue concluded that 5 or 6 “standard drinks” per day over extended periods resulted in “cognitive inefficiencies”, that 7 to 9 drinks per day resulted in “mild cognitive deficits”, and that 10 or more drinks per day caused impaired cognition of a degree encountered in frank alcoholics. In some studies heavy ethanol consumption (average 418g ethanol per week) correlated with reduced frontal lobe volume, whereas moderate consumption (181g per week) and light consumption (average 88g per week) did not. Some studies, moreover, found that light-to-moderate ethanol intake reduced the likelihood of dementia.

Reducing the Risk of Coronary Artery Disease and Ischemic Stroke

Relevant to such a protective effect of mild-to-moderate drinking on cognitive decline are its complex effects on coronary artery disease (CAD) and ischemic stroke. Numerous epidemiological studies, including prospective cohort studies, provide powerful evidence that one half to 2 drinks per day reduce the risk of myocardial infarction by roughly 25%, with 6 or more drinks per day increasing the risk. The result is a J-shaped curve, with mild-to-moderate ethanol intake reducing risk of CAD compared to non-drinking but heavy ethanol intake increasing risk. Concern has been expressed that the apparent protective effect is overestimated when non-drinkers are combined with former drinkers, who might have stopped drinking for reasons of ill health. However, separating former drinkers from longer-term abstainers in a large cohort study did not alter the results. Similarly, the protective effects remained after correcting for sociodemographic and other clinical characteristics. Benefit has been found for red and white wine, beer, and liquor.

A number of mechanisms appear to explain ethanol’s protective effect. Ethanol raises blood levels of high density lipoprotein cholesterol (HDL-C) in a dose-dependent fashion, and some studies suggest that this effect accounts for at least half of the protection against CAD. Ethanol also lowers high-density lipoprotein cholesterol, increases insulin sensitivity, prevents platelet aggregation, increases fibrinolysis, opposes thrombin activity, and reduces inflammatory markers. In addition, animal studies demonstrate a direct protective effect of ethanol on cardiac myocytes rendered ischemic; this effect has been linked to ethanol’s interactions with protein kinase C, adenosine receptors, and “cardioprotective proteins” that include superoxide dismutase, nitric oxide synthase, and heat shock proteins. It is speculated that some of the benefit might be attributable to antioxidant polyphenols such as resveratrol, which are especially abundant in red wine. In a rat model of cerebral infarction resveratrol reduced infarct volume, and the neuroprotection correlated with downregulation of inducible nitric oxide synthase (iNOS) and upregulation of endothelial nitric oxide synthase (eNOS).

A similar J-shaped curve describes the association of ethanol intake and ischemic stroke, although the protective effects of low-to-moderate intake are less dramatic. Meta-analysis of 19 cohort studies and 16 case-control studies (selected from a total of 122 reports) found that compared with abstention, consumption of less than 12 g ethanol per day reduced the risk of total stroke (relative risk, RR: 0.80); consumption of 12 to 24 g per day reduced the risk of ischemic stroke (RR: 0.72); and consumption of more than 60 g per day increased the risk of total stroke (RR: 1.64), ischemic stroke (RR:1.69), and hemorrhagic stroke (RR: 2.18). Light-to-moderate ethanol intake did not reduce the risk of hemorrhagic stroke. Subsequent cohort studies have shown comparable results. It is likely that similar effects on serum lipoproteins, coagulation factors, and platelets contribute to the reduced risk of both myocardial infarction and ischemic stroke conferred by low doses of ethanol, and antioxidants such as resveratrol (as well as the antioxidant properties of ethanol itself) might provide neuroprotection to the brain. In animal models of ischemic stroke, prior ethanol reduced delayed neuronal death, neuronal and dendritic degeneration, oxidative DNA damage, glial cell activation, and neutrophil infiltration.

Reducing the Risk of Dementia

The possibility that ethanol confers direct neuroprotection to the brain has obvious bearing on the apparent risk reduction of dementia in selected drinkers. Once again a J-shaped curve emerges, with moderate intake reducing the risk of cognitive impairment and heavy drinking increasing it. In the French PAQUID Study dementia was less prevalent among wine-drinkers, implicating anti-oxidant polyphenols, but few subjects in that study drank beer or liquor. Studies from around the world include the French PAQUID Study, the French Epidemiology of Vascular Aging Study, the National Heart Lung and Blood Institute Twin Study, the Rotterdam Study, the Copenhagan City Heart Study, the Chinese Nanjing University Study, the Italian Longitudinal Study on Aging, the Cardiovascular Health Study, the Nurses’ Health Study, the Washington Heights Inwood Columbia Aging Project, and the Prospective Population Study of Women in Göteborg, Sweden.

Studies have been both cohort and case-control, and subjects’ ages at enrollment have varied—in one study 59 to 69 years, in another 70 to 81 years. Study design has included enrollment of subjects considered cognitively normal or “non-demented” at outset, enrollment of subjects with “mild cognitive impairment”, and case-control analysis of demented subjects. In some studies protection from cognitive decline was conferred only by wine; others found either wine, beer, or liquor to be protective. In some studies, benefit was evident only in subjects carrying an APOEɛ4 allele, or an APOEɛ4 allele enhanced the protective effect. In other studies, benefit was evident only in subjects lacking an APOEɛ4 allele, or an APOEɛ4 allele reduced the protective effect. One study found no effect of APOEɛ4 genotype on risk reduction.

A 2008 meta-analysis reviewed 23 studies addressing the association of ethanol and incident dementia or cognitive decline. Twenty studies were epidemiological cohort and 3 were case-control nested in a cohort. The authors concluded that small amounts of ethanol probably protect against dementia (RR: 0.63) and Alzheimer disease (RR: 0.57) but not against vascular dementia (RR: 0.82, non-significant) or cognitive decline (RR: 0.89, non-significant). Studies varied as to what constituted optimal consumption or what defined a “standard drink.” Overall the evidence supported special benefit conferred by wine (but little evidence to favor red wine over white wine) and greater benefit in subjects lacking an APOEɛ4 allele. Two studies addressing concern that combining former drinkers with non-drinkers might result in spurious protection found that the positive benefit for ethanol was maintained when former drinkers were excluded. The authors of the meta-analysis emphasized that association is not the same as causation and that moderate drinkers, compared to abstainers and heavy drinkers, might “live healthier lives”.

Mild-to-moderate consumption of ethanol nonetheless appears to reduce the risk of dementia among older people, and the favorable effects of ethanol on cerebrovascular disease do not explain the benefit in non-vascular dementia. Animal models are consistent with these observations. “Alcohol-preferring” rats chronically consuming 15% ethanol/water were protected from apoptosis caused by inflammatory lipopolysaccharide injection. In brain cultures non-neurotoxic ethanol exposure protects against excitotoxic NMDA receptor mediated neurodegeneration, and the benefit paralleled induction of heat shock proteins. Neuroprotective effects, including those of polyphenol antioxidants as well as the antioxidant effects of ethanol itself, are plausible mechanisms for these effects. The Rotterdam Study investigators speculated that the greater benefit of ethanol among subjects with an APOEɛ4 allele might be related to ethanol’s ability to block oxidation of the apolipoprotein, thereby preventing it from binding to β-amyloid. Most studies, however, showed greatest benefit among subjects lacking an APOEɛ4 allele.

Perhaps surprisingly, the apparent neuroprotection observed in most epidemiological studies has not been reflected in imaging studies. Framingham Study investigators tested the hypothesis that moderate ethanol consumption would be associated with less age-related brain volume reduction and white matter lesions compared to either no drinking or heavy drinking. Not only was moderate ethanol intake not protective, but reduction in brain volume had a negative linear association with the amount of ethanol consumed (“abstainers”, “former drinkers”, “low”, “moderate”, “high”). Other studies also reported increased ventricular size, reduced grey matter volumes, or “brain atrophy” with increasing amounts of ethanol consumption. Two studies did demonstrate fewer cerebral white matter lesions in moderate drinkers.

Ethanol’s Effects on the Fetus

The fetal effects of ethanol involve a different kind of neurotoxicity. The fetal alcohol syndrome (FAS) is a triad consisting of CNS dysfunction, intrauterine growth deficiency, and distinctive facial dysmorphism; less often there are anomalies of the heart, skeleton, urogenital organs, skin and muscles. Symptoms include mental retardation, hypotonia, poor coordination, hyperactivity, and behavioral problems. Neuropathological features include microcephaly, abnormal cortical thickness, reduced cerebral white matter volume, and abnormalities of the corpus callosum and cerebellar vermis. Long-term follow-up demonstrates that mental retardation, abnormal behavior, and facial dysmorphism persist into adulthood. It is also evident that cognitive and behavioral abnormalities can occur in the absence of dysmorphisms, so-called “fetal alcohol effects”, “alcohol-related neurodevelopmental disorder”, (ARND) or “fetal alcohol spectrum disorders”.

Carefully controlled animal studies confirm that ethanol toxicity is the cause of FAS and that lower doses can produce impaired mental ability without other physical signs. Interestingly, although in humans with FAS the hippocampi are reportedly normal-sized, in rodents exposed in utero to ethanol the hippocampi display reduced number of neurons and dendritic spine density, correlating with the animals’ impaired learning and memory. Ethanol disrupts numerous developmental events in animal models, including neurogenesis, cell migration, cell adhesion, neuron survival, axon outgrowth, synapse formation, and neurotransmitter function. Animal studies include reports that “low-to-moderate” amounts of ethanol, a binge pattern of consumption, or even single exposures, can cause features of FAS.

Epidemiological studies in humans similarly raise the question of whether a “safe dose” of intrauterine ethanol exposure exists, with reports of FAS, low birth weight, decreased head circumference, dysmorphism, or subtle neurological and behavioral effects associated with 100 g ethanol per week, 10 g per day, or even 0.1 oz. per day. The validity of animal and human studies claiming teratogenicity of such low doses has not gone unchallenged, however, and whether there is a threshold of safety remains controversial. So are estimates of FAS prevalence, which range from 0.5 to 2.0 per 1000 births in the United States to 0.06 per 1000 births in Australia to 3.7–7.4 per 1000 in the Lazio province of Italy.

Proposed mechanisms for ethanol teratogenicity (not mutually exclusive) include vasospasm and CNS ischemia; blockade at glutamate NMDA receptors (which in fetal brain play a crucial role in neuronal differentiation); inhibition of the action of a neuronal cell adhesion molecule, L1, which in fetal brain mediates neurite outgrowth; and excessive activation of glycogen synthase kinase 3β, a serine/threonine kinase that regulates fetal neurogenesis, neuronal migration, synapse formation, and neuronal survival.

Conclusions

Identifying the mechanisms of ethanol’s multiple effects on cognition—including neurotoxicity, neuroprotection, interaction with nutritional deficiency, and teratology—will have obvious bearing not only on medical management but also on public policy.

References 156

  1. 1.

    Brust JCM Neurological Aspects of Substance Abuse2nd edButterworth-HeinemannBoston, MA, USA2004 317425

    Not in our library

  2. 2.

    Hanson GR Li T-K Public health implications of excessive alcohol consumptionJAMA2003 28910311032

    Not in our library10.1001/jama.289.8.1031

  3. 3.

    Tupala E Tiihonen J Dopamine and alcoholism: neurobiological basis of alcohol abuseProg. Neuropsychopharmacol. Biol. Psychiatry2004 2812211247

    Not in our library10.1016/j.pnpbp.2004.06.022

  4. 4.

    Davis KM Wu J-Y Role of glutamatergic and GABAergic systems in alcoholismJ. Biomed. Sci2001 8719

    Not in our library10.1007/bf02255966

  5. 5.

    Koch-Weser J Sellers EM Kalent HL Alcohol intoxication and withdrawalN. Engl. J. Med1976 294757762

    Not in our library10.1056/nejm197604012941405

  6. 6.

    Fox A Kay J Taylor A The course of alcohol withdrawal in a general hospitalQJM1997 90253261

    Not in our library10.1093/qjmed/90.4.253

  7. 7.

    Ng SKC Hauser WA Brust JCM Susser M Alcohol consumption and withdrawal in new onset seizuresN. Engl. J. Med1988 319666673

    Not in our library10.1056/nejm198809153191102

  8. 8.

    Kosten TR O’Connor PG Management of drug and alcohol withdrawalN. Engl. J. Med2003 34817861795

    Not in our library10.1056/nejmra020617

  9. 9.

    Rivara FP Koepsell TD Jurkovich G Gurney JG Soderberg R The effects of alcohol abuse on readmission for traumaJAMA1993 27019621964

    Not in our library

  10. 10.

    Cook RT Alcohol abuse, alcoholism and damage to the immune system—a reviewAlcohol Clin. Exp. Res1998 2219271942

    Not in our library

  11. 11.

    Malouf R Brust JCM Hypoglycemia: causes, neurological manifestations, and outcomeAnn. Neurol1985 17421430

    Not in our library10.1002/ana.410170502

  12. 12.

    Lizardi-Cervera J Almeda P Guevara L Uribe M Hepatic encephalopathy: a reviewAnn Hepatol2003 2122130

    Not in our library

  13. 13.

    Osborn HH EthanolGoldfrank’s Toxicologic Emergencies6th edGoldfrank LR Flomenbaum NE Lewin NA Weisman RS Howland M Hoffman RS Appleton & LangeStamford, CT, USA1998 10231041

    Not in our library

  14. 14.

    Kohler CG Ances BM Coleman AR Ragland JD Lazarev M Gur RC Marchiafava-Bignami disease: literature review and case reportNeuropsychiatry Neuropsychol. Behav. Neurol2000 136776

    Not in our library

  15. 15.

    Serdaru M Hausser-Hauw C Laplane D Buge A Castaigne P Goulan M Lhermitte F Hauw JJ The clinical spectrum of alcoholic pellagra encephalopathyBrain1988 111829842

    Not in our library10.1093/brain/111.4.829

  16. 16.

    Victor M Adams RD Collins GH The Wernicke-Korsakoff Syndrome2nd edFA DavisPhiladelphia, PA, USA1989

    Not in our library

  17. 17.

    Caine D Halliday GM Kril JJ Harper CG Operational criteria for the classification of chronic alcoholics: identification of Wernicke’s encephalopathyJ. Neurol. Neurosurg. Psychiatry1997 625160

    Not in our library10.1136/jnnp.62.1.51

  18. 18.

    Homewood J Bond NW Thiamine deficiency and Korsakoff’s syndrome: failure to find memory impairments following nonalcoholic Wernicke’s encephalopathyAlcohol1999 197584

    Not in our library10.1016/s0741-8329(99)00027-0

  19. 19.

    Kopelman MD The Korsakoff syndromeBr. J. Psychiatry1995 166154173

    Not in our library10.1192/bjp.166.2.154

  20. 20.

    Robinson JK Mair RG MK-801 prevents brain lesions and delayed-nonmatching-to-sample deficits produced by pyrithiamine-induced encephalopathy in ratsBehav. Neurosci1992 106623633

    Not in our library

  21. 21.

    Cheon Y Park J Joe K-H Kim DJ The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementiaInt. J. Neuropsychopharmacol2008 11971983

    Not in our library10.1017/s1461145708008663

  22. 22.

    Rustembegovic A Kundurovic Z Sapcanin A Sofic E A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndromeMed. Arkhiv2003 57149150

    Not in our library

  23. 23.

    Cochrane M Cochrane A Jauhar P Ashton E Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome—three further cases show response to donezepilAlcohol Alcohol2005 40151154

    Not in our library10.1093/alcalc/agh127

  24. 24.

    Gibson RC Barnaby L Rivastigmine in the treatment of alcohol-induced persisting dementiaWest Indian Med. J2003 525961

    Not in our library

  25. 25.

    Victor M Adams RD Mancall EL A restricted form of cerebellar cortical degeneration occurring in alcoholic patientsArch. Neurol1959 71579588

    Not in our library

  26. 26.

    Mancall EL McEntee WJ Alterations of the cerebellar cortex in nutritional encephalopathyNeurology1965 15303313

    Not in our library

  27. 27.

    Dlugos CA Pentney RJ Morphometric evidence that the total number of neurons on Purkinje neurons of old F344 rats is reduced after long-term ethanol treatment and restores to control after recoveryAlcohol1997 32161172

    Not in our library10.1093/oxfordjournals.alcalc.a008250

  28. 28.

    Pantazis NJ Dohrman DP Luo J Thomas JD Goodlet CR West JR NMDA prevents alcohol-induced neuronal cell death of cerebellar granule cells in cultureAlcohol Clin. Exp. Res1995 19846853

    Not in our library10.1111/j.1530-0277.1995.tb00957.x

  29. 29.

    Shimozono M Townsend JC Ilsen PF Bright DC Acute vision loss resulting from complications of ethanol abuseJ. Am. Optomet. Assoc1998 69293303

    Not in our library

  30. 30.

    Koike H Iljima M Sugiura M Mori K Hattori N Ito H Hirayama M Sobue G Alcoholic neuropathy is clinicopathologically distinct from thiamine deficiency neuropathyAnn. Neurol2003 541929

    Not in our library10.1002/ana.10550

  31. 31.

    Gazdzinski S Dorazzo TC Meyerhoff DJ Temporal dynamics and determinants of whole brain tissue volume changes during recovery from alcohol dependenceDrug Alcohol Depend2005 78263273

    Not in our library10.1016/j.drugalcdep.2004.11.004

  32. 32.

    Gupta S Warner J Alcohol-related dementia: a 21st-century silent epidemic?Br. J. Psychiatry2008 193351353

    Not in our library10.1192/bjp.bp.108.051425

  33. 33.

    Harper CJ Kril J Daly J Are we drinking our neurons away?BMJ1987 294539536

    Not in our library10.1136/bmj.294.6571.534

  34. 34.

    Smith DM Atkinson RM Alcoholism and dementiaInt. J. Addict1995 3018431869

    Not in our library10.3109/10826089509071058

  35. 35.

    Oslin DW Atkinson RM Smith DM Hendrie H Alcohol related dementia: proposed clinical criteriaInt. J. Geriatric Psychiatry1998 13203212

    Not in our library10.1002/(sici)1099-1166(199804)13:4<203::aid-gps734>3.0.co;2-b

  36. 36.

    File SE Mabbutt PS Long-lasting effects on habituation and passive avoidance performance of a period of chronic ethanol administration in the ratBehav. Brain Res1990 36171178

    Not in our library10.1016/0166-4328(90)90171-a

  37. 37.

    Walker DW Hunter BE Abraham WC Neuroanatomical and functional deficits subsequent to chronic ethanol administration in animalsAlcohol Clin. Exp. Res1981 5267282

    Not in our library10.1111/j.1530-0277.1981.tb04901.x

  38. 38.

    Phillips SC The threshold concentration of dietary ethanol necessary to produce toxic effects of hippocampal cells and synapses in the mouseExp. Neurol1989 1046872

    Not in our library10.1016/0014-4886(89)90010-1

  39. 39.

    Durand D Saint-Cyr JA Gurevich N Carlen PL Ethanol-induced dendritic alterations in hippocampal granule cellsBrain Res1989 477373377

    Not in our library10.1016/0006-8993(89)91430-3

  40. 40.

    Bengoechea O Gonzalo LM Effects of alcoholization in the rat hippocampusNeurosci. Lett1991 123112114

    Not in our library10.1016/0304-3940(91)90170-x

  41. 41.

    Collins MA Corso TD Neafsey EJ Neuronal degeneration in rat cerebrocortical and olfactory regions during subchronic “binge” intoxication with ethanol: possible explanation for olfactory deficits in alcoholicsAlcohol Clin. Exp. Res1996 20284292

    Not in our library10.1111/j.1530-0277.1996.tb01641.x

  42. 42.

    Ferrer I Galofre E Fabriques Lopez-Tejero D Effects of chronic ethanol consumption beginning at adolescence: increased numbers of dendritic spines on cortical pyramidal cells in adulthoodActa. Neuropathol1989 78528532

    Not in our library10.1007/bf00687715

  43. 43.

    Lundqvist C Alling C Knoth Volk B Intermittent ethanol exposure of adult rats. Hippocampal cell loss after one month of treatmentAlcohol1995 30737748

    Not in our library

  44. 44.

    Arendt T Henning D Gray JA Marchbanks R Loss of neurons in the rat basal forebrain cholinergic projection system after prolonged intake of ethanolBrain Res. Bull1988 21563569

    Not in our library10.1016/0361-9230(88)90193-1

  45. 45.

    Benthius DJ West JR Ethanol-induced neuronal loss in the developing rats: increased brain damage with binge exposureAlcohol Clin. Exp. Res1990 14107118

    Not in our library10.1111/j.1530-0277.1990.tb00455.x

  46. 46.

    Harper C The neurobiology of alcohol-specific brain damage, or does alcohol damage the brain?J. Neuropathol. Exp. Neurol1998 57101110

    Not in our library10.1097/00005072-199802000-00001

  47. 47.

    Ravaglia S Costa A Ratti MT Savoldi E Bo P Moglia A Cognitive impairment and central motor conduction time in chronic alcoholicsFunct. Neurol2002 178386

    Not in our library

  48. 48.

    Sullivan EV Compromised pontocerebellar and cerebellothalamocortical systems: speculations on their contribution to cognitive and motor impairment in nonamnesic alcoholismAlcohol Clin. Exp. Res2003 2714091419

    Not in our library10.1097/01.alc.0000085586.91726.46

  49. 49.

    Kril JJ Halliday GM Brain shrinkage in alcoholics: a decade on and what have we learned?Prog. Neurobiol1999 58381387

    Not in our library10.1016/s0301-0082(98)00091-4

  50. 50.

    Pfefferbaum A Sullivan EV Hedehus M Adalsteinsson E Lim KO Moseley M In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholismAlcohol Clin. Exp. Res2000 2412141221

    Not in our library

  51. 51.

    Shear PK Jernigan TL Butters N Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholicsAlcohol Clin. Exp. Res1994 18172176

    Not in our library10.1111/j.1530-0277.1994.tb00899.x

  52. 52.

    Di Scalfani V Ezekiel F Meyerhoff DJ Mackay S Dillonv VVP Weimer MWV Fein G Brain atrophy and cognitive function in older abstinent alcoholic menAlcohol Clin. Exp. Res1995 1911211126

    Not in our library10.1111/j.1530-0277.1995.tb01589.x

  53. 53.

    Estilaei MR Matson GB Payne GS Leach MO Fein G Meyerhoff DJ Effects of chronic alcohol consumption on the broad phospholipid signal in human brain: an in vivo 31P MRS studyAlcohol Clin. Exp. Res2001 258997

    Not in our library

  54. 54.

    Pfefferbaum A Sullivan EV Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imagingNeuropsychopharmacology2005 30423432

    Not in our library10.1038/sj.npp.1300623

  55. 55.

    Harper C Matsumoto I Ethanol and brain damageCurr. Op. Pharmacol2005 57378

    Not in our library10.1016/j.coph.2004.06.011

  56. 56.

    Schweinsburg BC Taylor MJ Alhassoon OM Videan JS Brown GG Patterson TL Berger F Grant T Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injuryAlcohol Clin. Exp. Res2001 25924934

    Not in our library

  57. 57.

    Bron A Anderson J Frontal dysfunction and frontal cortical synapse loss in alcoholism: the main cause of alcohol dementia?Dement. Geriatr. Cogn. Disord2001 12289294

    Not in our library10.1159/000051271

  58. 58.

    Monnot M Nixon S Lovallo W Ross E Altered emotional perception in alcoholics: deficits in affective prosody comprehensionAlcohol Clin. Exp. Res2001 25362369

    Not in our library

  59. 59.

    Harper C Corbett D Changes in the basal dendrites of cortical pyramidal cells from alcoholic patients—a quantitative Golgi studyJ. Neurol. Neurosurg. Psychiatry1990 53856861

    Not in our library10.1136/jnnp.53.10.856

  60. 60.

    Mann K Ackerman B Croissant B Mundle G Nakovics H Diehl A Neuroimaging of gender differences in alcohol dependence: are women more vulnerable?Alcohol Clin. Exp. Res2005 29896901

    Not in our library10.1097/01.alc.0000164376.69978.6b

  61. 61.

    Duka T Townshend JM Collier K Stephens DN Impairment in cognitive functions after multiple detoxifications in alcoholic inpatientsAlcohol Clin. Exp. Res2003 2715631572

    Not in our library10.1097/01.alc.0000090142.11260.d7

  62. 62.

    Tsai G Coyle JT The role of glutamatergic neurotransmission in the pathophysiology of alcoholismAnnu. Rev. Med1998 49173184

    Not in our library10.1146/annurev.med.49.1.173

  63. 63.

    Chandler LJ Newsom H Sumners C Crews F Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neuronsJ. Neurochem1993 6015781581

    Not in our library10.1111/j.1471-4159.1993.tb03326.x

  64. 64.

    Gotz ME Janetsky B Pohli S Gottschalk A Gsell W Tatschner T Ransmayr G Leblhuber F Gerlach M Reichmann H Riederer P Böning J Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link?Alcohol Clin. Exp. Res2001 25717725

    Not in our library

  65. 65.

    Stepanyan TD Farook JM Kowalski A Kaplan E Barron S Littleton JM Alcohol withdrawal-induced hippocampal neurotoxicity in vitro and seizures in vivo are both reduced by memantineAlcohol Clin. Exp. Res2008 3221282135

    Not in our library10.1111/j.1530-0277.2008.00801.x

  66. 66.

    Krupitsky EM Neznanova O Masalov D Burakov AM Didenko T Romanova T Tsoy M Bespalov A Slavina TY Grinenko AA Petrakis IL Pittman B Gueorguieva R Zvartau EE Krystal JH Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patientsAm. J. Psychiatry2007 164519523

    Not in our library10.1176/ajp.2007.164.3.519

  67. 67.

    Bleich S Bandelow B Javaheripour K Müller A Degner D Wilhelm J Havemann-Reinecke U Spurling W Ruther E Kornhuber J Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholismNeurosci. Lett2003 335179182

    Not in our library10.1016/s0304-3940(02)01194-1

  68. 68.

    Robinson G Narasimhan S Weatherall M Beasley R Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia?N. Z. Med. J2005 118U1490

    Not in our library

  69. 69.

    Wilhelm J Bayerlein K Hillemacher T Reulback U Friehling H Kromdan B Degner D Kornhuber J Bleich S Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholismJ. Neurol. Transmission2006 113357363

    Not in our library10.1007/s00702-005-0333-1

  70. 70.

    Miller R King MA Heaton MB Walker DW The effects of chronic ethanol consumption on neurotrophins and their receptors in the rat hippocampus and basal forebrainBrain Res2002 950137147

    Not in our library10.1016/s0006-8993(02)03014-7

  71. 71.

    Lamarche F Gonthier B Signorini N Eysseric H Barret L Acute exposure of cultured neurons to ethanol results in reversible DNA single-strand breaks; whereas chronic exposure causes loss of cell viabilityAlcohol Alcohol2003 38550558

    Not in our library10.1093/alcalc/agg118

  72. 72.

    Niemela O Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injuryFree Radic. Biol. Med2001 3115331538

    Not in our library10.1016/s0891-5849(01)00744-4

  73. 73.

    Butterworth RF Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver diseaseMetab. Brain Dis1995 1018

    Not in our library10.1007/bf01991777

  74. 74.

    Harper C Dixon G Sheedy D Garrick T Neuropathological alterations in alcoholic brains. Studies arising from New South Wales Tissue Resource CentreProg. Neuropsychopharmacol. Biol. Psychiatry2003 27951961

    Not in our library10.1016/s0278-5846(03)00155-6

  75. 75.

    Parsons OA Nixon SJ Cognitive functioning in sober social drinkers: a review of the research since 1986J. Stud. Alcohol1998 59180190

    Not in our library10.15288/jsa.1998.59.180

  76. 76.

    Kubota M Nakazaki S Hirai S Saeki N Yamaura A Kusaka T Alcohol consumption and frontal lobe shrinkage: study of 1432 non-alcoholic subjectsJ. Neurol. Neurosurg. Psychiatry2001 71104106

    Not in our library10.1136/jnnp.71.1.104

  77. 77.

    Launer LJ Feskens EJ Kalmijn S Kromhout D Smoking, drinking, and thinking: the Zutphen Elderly StudyAm. J. Epidemiol1996 143219227

    Not in our library10.1093/oxfordjournals.aje.a008732

  78. 78.

    Galanis DJ Joseph C Masaki KH Petrovitch H Ross GW White L A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging StudyAm. J. Public Health2000 9012541259

    Not in our library10.2105/ajph.90.8.1254

  79. 79.

    Lemeshow S Letenneur L Dartigues JF Lafont S Orgogozo JM Commenges D Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID studyAm. J. Epidemiol1998 148298306

    Not in our library10.1093/oxfordjournals.aje.a009639

  80. 80.

    Ruitenberg A van Swieten JC Witteman JCM Mehta KM van Duijn CM Hoffman A Breteler MM Alcohol consumption and the risk of dementia: the Rotterdam StudyLancet2002 359281286

    Not in our library10.1016/s0140-6736(02)07493-7

  81. 81.

    Truelson T Thudium D Gronbaek M Amount and type of alcohol and risk of dementia: the Copenhagen City Heart StudyNeurology2002 5913131319

    Not in our library10.1212/01.wnl.0000031421.50369.e7

  82. 82.

    Mukamal KJ Kuller LH Fitzpatrick AL Longstreth WT Mittleman MA Siscovick DS Prospective study of alcohol consumption and risk of dementia in older adultsJAMA2003 28914051413

    Not in our library10.1001/jama.289.11.1405

  83. 83.

    Espeland MA Gu L Masaki KH Association between reported alcohol intake and cognition: results from the Women’s Health Initiative Memory StudyAm. J. Epidemiol2005 161228238

    Not in our library10.1093/aje/kwi043

  84. 84.

    Bond GE Burr RL McCurry SM Rice MM Borenstein AR Larson EB Alcohol and cognitive performance: a longitudinal study of older Japanese Americans. The Kame ProjectInt. Psychogeriatr2005 17653668

    Not in our library10.1017/s1041610205001651

  85. 85.

    Leroi I Sheppard JM Lyketsos CG Cognitive function after 11.5 years of alcohol use: relation to alcohol useAm. J. Epidemiol2002 156747752

    Not in our library10.1093/aje/kwf107

  86. 86.

    Kalmijn S van Boxtel MPJ Verschuren MWM Jolles J Launer LJ Cigarette smoking and alcohol consumption in relation to cognitive performance in middle ageAm. J. Epidemiol2002 156936944

    Not in our library10.1093/aje/kwf135

  87. 87.

    Collins MA Neafsey EJ Mukamal KJ Gray MO Parks DA Das OK Korthuis RJ Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studiesAlcohol Clin. Exp. Res2009 33206219

    Not in our library10.1111/j.1530-0277.2008.00828.x

  88. 88.

    Cleophas TJ Wine, beer and spirits and the risk of myocardial infarction: a systematic reviewBiomed. Pharmacother1999 53417423

    Not in our library10.1016/s0753-3322(99)80121-8

  89. 89.

    Corrao G Rubbiati L Bagnardi V Zambon A Poikolainen K Alcohol and coronary artery disease: a meta-analysisAddiction2000 9515051523

    Not in our library10.1046/j.1360-0443.2000.951015056.x

  90. 90.

    Freiberg MS Samet JH Alcohol and coronary heart disease: the answer awaits a randomized controlled trialCirculation2005 11213791381

    Not in our library10.1161/circulationaha.105.568030

  91. 91.

    Fillmore KM Stockwell T Chikritzhs T Bostrom A Kerr W Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypothesesAnn. Epidemiol2007 17S16S23

    Not in our library10.1016/j.annepidem.2007.01.005

  92. 92.

    Mukamal KJ Conigrave KM Mittleman MA Camargo CA Jr Stamfer MJ Willett WC Rimm EB Roles of drinking and type of alcohol consumed in coronary heart disease in menN. Engl. J. Med2003 348109118

    Not in our library10.1056/nejmoa022095

  93. 93.

    Mukamal KJ Chung H Jenny NS Kuller LH Longstreth WT Jr Mittleman MA Burke GL Cushman M Psaty BM Siskovic DS Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health StudyJ. Am. Geriatr. Soc2006 543037

    Not in our library10.1111/j.1532-5415.2005.00561.x

  94. 94.

    Mukamal KJ Jensen MK Gronback M Stamfer MJ Manson JE Pischon T Rimm EB Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and menCirculation2005 11214061413

    Not in our library10.1161/circulationaha.105.537704

  95. 95.

    Davies MJ Baer DJ Judd JT Brown ED Campbell WS Taylor PR Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trialJAMA2002 28725592562

    Not in our library10.1001/jama.287.19.2559

  96. 96.

    Renaud SC Ruf JC Effects of alcohol on platelet functionClin. Chim. Acta1996 2467789

    Not in our library10.1016/0009-8981(96)06228-6

  97. 97.

    Aikens ML Grenett HE Benza RL Tabengua EM Davis GC Booyse FM Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cellsAlcohol Clin. Exp. Res1998 22375381

    Not in our library

  98. 98.

    Sierksma A van der Gaag MS Kluft C Hendricks HF Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels: a randomized, diet-controlled intervention studyEur. J. Clin. Nutr2002 5611301136

    Not in our library10.1038/sj.ejcn.1601459

  99. 99.

    Das S Khan N Mukherjee S Bagchi D Gurusamy N Swartz H Das DK Redox regulation of resveratrol-mediated switching of death signal into survival signalFree Radic. Biol. Med2008 448290

    Not in our library10.1016/j.freeradbiomed.2007.09.008

  100. 100.

    Juric D Wojciechowski P Das DK Nettícadan T Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrolAm. J. Physiol. Heart. Circ. Physiol2007 292H2138H2143

    Not in our library10.1152/ajpheart.00852.2006

  101. 101.

    Mokni M Limam F Elkahoui S Amri M Aouani E Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia-reperfusion injuryArch. Biochem. Biophys2007 45716

    Not in our library10.1016/j.abb.2006.10.015

  102. 102.

    Tsai S-K Hung L-M Fu Y-T Cheng H Nien MW Liu HY Zhang FB Huang SS Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in ratsJ. Vasc. Surg2007 46346353

    Not in our library10.1016/j.jvs.2007.04.044

  103. 103.

    Reynolds K Lewis B Nolen JD Kinney GL Sathya B He J Alcohol consumption and risk of stroke: a meta-analysisJAMA2003 289579588

    Not in our library10.1001/jama.289.5.579

  104. 104.

    Mukamal KJ Ascherio A Mittleman MA Conigrave KM Camargo CA Jr Kawachi I Stamfer MJ Willett WC Rimm EB Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverageAnn. Intern. Med2005 1421119

    Not in our library10.7326/0003-4819-142-1-200501040-00007

  105. 105.

    Mukamal KJ Chung H Jenny NS Kuller LH Longstreth WT Jr Mittleman MA Burke GL Cushman M Beauchamp NJ Jr Alcohol use and risk of ischemic stroke among older adults. The Cardiovascular Health StudyStroke2005 3618301834

    Not in our library10.1161/01.str.0000177587.76846.89

  106. 106.

    Wang Q Sun AY Simonyi A Kalogeris TJ Miller DK Sun GY Korthuis RJ Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROSFree Radic. Biol. Med2007 4310481060

    Not in our library10.1016/j.freeradbiomed.2007.06.018

  107. 107.

    Orgogozo JM Dartigues JF LaFont S Letenneur L Commenges D Salamon R Renaud S Breteler MB Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux areaRev. Neurol1997 153185192

    Not in our library

  108. 108.

    Larrieu S Letenneur L Helmer C Dartigues JF Barberger-Gateau P Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohortJ. Nutr. Health Aging2004 8150154

    Not in our library

  109. 109.

    Dufouil C Tzourio C Brayne C Berr C Amouyel P Alperovitch A Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokersEpidemiology2000 11280284

    Not in our library10.1097/00001648-200005000-00009

  110. 110.

    Carmelli D Swan GE Reed T Schellenberg GD Christian JC The effect of apolipoprotein Eɛ4 in the relationships of smoking and drinking to cognitive functionNeuroepidemiology1999 18125133

    Not in our library10.1159/000026204

  111. 111.

    Zu G Liu X Yin Q Zhu W Zhang R Fan X Alcohol consumption and transition of mild cognitive impairment to dementiaPsychiatry Clin. Neurosci2009 634349

    Not in our library10.1111/j.1440-1819.2008.01904.x

  112. 112.

    Solfrizzi V D’Introno A Colacicco M Capurso C Del Parigi A Baldassarre G Scapicchio P Scafato E Amodio M Capurso A Panza F Italian Longitudinal Study on Aging Working GroupAlcohol consumption, mild cognitive impairment, and progression to dementiaNeurology2007 6817901799

    Not in our library10.1212/01.wnl.0000262035.87304.89

  113. 113.

    Panza F Capurso C D’Introno A Colacicco AM Frisardi V Lorusso M Santamato A Seripa D Pilotto A Scarfato E Vendemiate G Capurso A Solfrizzi V Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromesJ. Alzheimer Dis2009 17731

    Not in our library10.3233/jad-2009-1009

  114. 114.

    Stampfer MJ Kang JH Chen J Effects of moderate alcohol consumption on cognitive function in womenN. Engl. J. Med2005 352245253

    Not in our library10.1056/nejmoa041152

  115. 115.

    Luchsinger JA Tang M-X Siddiqui M Shea S Mayeux R Alcohol intake and risk of dementiaJ. Am. Geriatr. Soc2004 52540546

    Not in our library10.1111/j.1532-5415.2004.52159.x

  116. 116.

    Mehlig K Skoog I Guo X Schutze M Gustofson D Waern M Ostling S Bjorkelund C Lissner L Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in GöteborgAm. J. Epidemiol2008 167684691

    Not in our library10.1093/aje/kwm366

  117. 117.

    Peters R Peters J Warner J Beckett N Bulpitt C Alcohol, dementia and cognitive decline in the elderly: a systematic reviewAge Aging2008 37505512

    Not in our library10.1093/ageing/afn095

  118. 118.

    Ganguli M Vander Bilt J Saxton J Shen C Dodge HH Alcohol consumption and cognitive function in late life: a longitudinal community studyNeurology2005 6512101217

    Not in our library10.1212/01.wnl.0000180520.35181.24

  119. 119.

    Singh AK Jiang Y Gupta S Benlhabib E Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injectionAlcohol Alcohol2007 42385399

    Not in our library10.1093/alcalc/agl120

  120. 120.

    Belmadani A Neafsey EJ Collins MA Human immunodeficiency virus type 1 gp120 and ethanol coexposure in rat organotypic brain slice cultures: curtailment of gp120-induced neurotoxicity and neurotoxic mediators by moderate but not high ethanol concentrationsJ. Neurovirol2003 94554

    Not in our library10.1080/13550280390173409

  121. 121.

    Belmadani A Kumar S Schipma M Collins MA Neafsey EJ Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioningNeuroreport2004 1520932096

    Not in our library10.1097/00001756-200409150-00019

  122. 122.

    Paul CA Au R Fredman L Massaro JM Seshadri S DeCarli C Wolf PA Association of alcohol consumption with brain volume in the Framingham StudyArch. Neurol2008 6513631367

    Not in our library10.1001/archneur.65.10.1363

  123. 123.

    Mukamal KJ Longstreth WT Jr Mittleman MA Crum RM Siscovic DS Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the Cardiovascular Health StudyStroke2001 3219391946

    Not in our library10.1161/hs0901.095723

  124. 124.

    Ding J Eigenbrodt M Mosley TH Jr Hutchinson RG Folsom AR Nieto FG Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adultsStroke2004 351621

    Not in our library10.1161/01.str.0000105929.88691.8e

  125. 125.

    Taki Y Kinomura S Sato K Goto R Inoue K Okada K Ono S Kawashima R Fukuda H Both global gray matter volume and regional gray matter volume negatively correlate with lifetime alcohol intake in non-alcohol-dependent Japanese men: a volumetric analysis and a voxel-based morphometryAlcohol Clin. Exp. Res2006 3010451050

    Not in our library10.1111/j.1530-0277.2006.00118.x

  126. 126.

    Ansley KJ Jorm A Reglade-Mesin R Maller J Kumar R von Sanden C Windsor TD Rodgers B Wen W Sachdev P Weekly alcohol consumption, brain atrophy and white matter hyperintensities in a community-based sample aged 60 to 64 yearsPsychosom. Med2006 68778785

    Not in our library10.1097/01.psy.0000237779.56500.af

  127. 127.

    den Heijer T Vermeer SE van Dijk EJ Prins ND Koudstaal PJ van Duijn CM Hofman A Breteler MM Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementiaAm. J. Clin. Nutri2004 80992997

    Not in our library10.1093/ajcn/80.4.992

  128. 128.

    Colangelo W Jones DG The fetal alcohol syndrome: a review and assessment of the syndrome and its neurological sequelaeProg. Neurobiol1982 19271314

    Not in our library10.1016/0301-0082(82)90009-0

  129. 129.

    Mattson SN Riley EP Gramling L Delis DC Jones KL Neuro-psychological comparison of alcohol-exposed children with and without physical features of fetal alcohol syndromeNeuropsychology1998 12146153

    Not in our library10.1037//0894-4105.12.1.146

  130. 130.

    Lemoine P Lemoine P Avenir des enfants de mères alcoholiques (étude de 105 cas retrouvés a l’age adult) et quelques constatations d’intérêt prophylactiqueAnn. Pediatr1992 29226235

    Not in our library

  131. 131.

    D’Onofrio BM van Hulle CA Waldman ID Rodgers JL Rathouz PJ Lahey BB Causal inferences regarding prenatal alcohol exposure and childhood externalizing problemsArch. Gen. Psychiatry2007 6412961304

    Not in our library10.1001/archpsyc.64.11.1296

  132. 132.

    Riley EP McGee CL Fetal alcohol spectrum disorders; an overview with emphasis on changes in brain and behaviorExp. Biol. Med2005 230357365

    Not in our library10.1177/15353702-0323006-03

  133. 133.

    O’Malley KD Nanson J Clinical implications of a link between fetal alcohol spectrum disorder and attention-deficit hyperactivity disorderCan. J. Psychiatry2002 47349354

    Not in our library10.1177/070674370204700405

  134. 134.
    Teratogenic effects of alcohol on brain and behavior. · 2001
    No notice
  135. 135.

    O’Callaghan FV O’Callaghan M Najman JM Williams GM Bor W Maternal alcohol consumption during pregnancy and physical outcomes up to 5 years of age: a longitudinal studyEarly Hum. Dev2003 71137148

    Not in our library10.1016/s0378-3782(03)00003-3

  136. 136.

    O’Callaghan FV O’Callaghan M Najman JM Williams JM Bor W Prenatal alcohol exposure and attention, learning, and intellectual ability at 14 years: a prospective longitudinal studyEarly Hum. Dev2007 83115123

    Not in our library10.1016/j.earlhumdev.2006.05.011

  137. 137.

    Cudd TA Animal model systems for the study of alcohol teratologyExp. Biol. Med2005 230389393

    Not in our library10.1177/15353702-0323006-06

  138. 138.

    Berman RF Hannigan JH Effects of prenatal alcohol exposure on the hippocampus: spatial behavior, electrophysiology, and neuroanatomyHippocampus2000 1094110

    Not in our library10.1002/(sici)1098-1063(2000)10:1<94::aid-hipo11>3.0.co;2-t

  139. 139.

    Kumada T Jiang Y Cameron DB Kamuro H How does alcohol impair neuronal migration?J. Neurosci. Res2007 85465470

    Not in our library10.1002/jnr.21149

  140. 140.

    Hoffman EJ Mintz CD Wang S McNickle DG Salton SR Benson DL Effects of ethanol on axon outgrowth and branching in developing rat cortical neuronsNeuroscience2008 157556565

    Not in our library10.1016/j.neuroscience.2008.08.071

  141. 141.

    Luo J GSK3β in ethanol neurotoxicityMol. Neurobiol2009 40108121

    Not in our library10.1007/s12035-009-8075-y

  142. 142.

    Clarren SK Bowden DM Fetal alcohol syndrome: a new primate model for binge drinking and its relevance to human ethanol teratogenesisJ. Pediatr1982 2203213

    Not in our library10.1016/s0022-3476(82)80340-5

  143. 143.

    Sulik KK Lauder JM Dehart DB Brain malformations in prenatal mice following acute maternal ethanol administrationInt. J. Dev. Neurosci1984 2203213

    Not in our library10.1016/0736-5748(84)90014-5

  144. 144.

    Sulik K Johnston MC Webb MA Fetal alcohol syndrome: embryogenesis in a mouse modelScience1981 214936938

    Not in our library10.1126/science.6795717

  145. 145.

    Wright JT Waterson EJ Barrison IG Toplis PJ Lewis IG Gordon MG MacRae KD Morris NF Murray-Lyon IM Alcohol consumption, pregnancy, and low birthweightLancet1983 1663665

    Not in our library10.1016/s0140-6736(83)91964-5

  146. 146.

    Alpert J Zuckerman B High blood alcohol levels in womenN. Engl. J. Med1990 3236066

    Not in our library

  147. 147.

    Mills JL Graubard BI Harley EE Rhoads GG Berendes HW Maternal alcohol consumption and birthweight: how much drinking during pregnancy is safe?JAMA1984 25218751879

    Not in our library

  148. 148.

    Little RE Asker RL Sampson PD Renwick JH Fetal growth and moderate drinking in early pregnancyAm. J. Epidemiol1986 123270278

    Not in our library10.1093/oxfordjournals.aje.a114235

  149. 149.

    Gray R Mukherjee RAS Rutter M Alcohol consumption during pregnancy and its effects on neurodevelopment: what is known and what remains uncertainAddiction2009 10412701273

    Not in our library10.1111/j.1360-0443.2008.02441.x

  150. 150.

    Abel EL Fetal alcohol syndrome: same old, same oldAddiction2009 10412741280

    Not in our library10.1111/j.1360-0443.2008.02481.x

  151. 151.
    Estimating the prevalence of fetal alcohol syndrome. A summary. · 2001
    No notice
  152. 152.

    Elliott EJ Payne J Morris A Haan E Bower C Fetal alcohol syndrome: a prospective national surveillance studyArch. Dis. Child2008 93732737

    Not in our library10.1136/adc.2007.120220

  153. 153.

    May PA Fiorentino D Gossage JP Kalberg WO Hoyme H Robinson LK Coriale G Jones KL del Campo M Tarani L Epidemiology of FASD in a province in Italy: prevalence and characteristics of children in a random sample of schoolsAlcohol Clin. Exp. Res2006 3015621575

    Not in our library10.1111/j.1530-0277.2006.00188.x

  154. 154.

    Mukherjee AB Hodgen GD Maternal ethanol exposure induces transient impairment of umbilical circulation and fetal hypoxia in monkeysScience1982 218700702

    Not in our library10.1126/science.6890235

  155. 155.

    Kumari M Tucku MK Ethanol and regulation of the NMDA receptor subunits in fetal cortical neuronsJ. Neurochem1998 7014671473

    Not in our library10.1046/j.1471-4159.1998.70041467.x

  156. 156.

    Yeaney NK He M Tang N Malouf AT O’Riorden MA Lemmon V Bearer CF Ethanol inhibits L1 cell adhesion molecule tyrosine phosphorylation and dephosphorylation and activation of pp60srcJ. Neurochem2009 110779790

    Not in our library10.1111/j.1471-4159.2009.06143.x

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.